Innovative People
Takis Athanasopoulos
: Novel HIV vaccine vector development (viral: Ad, AAV, lenti- & non-viral), Genetic Vaccines, development of Adeno-Associated Viral (rAAV) vectors for Gene therapy of cardiovascular, neuromuscular and neurodegenerative disease; HIV immunobiology and Cell & Molecular Biology of muscle, Development of plasmid and viral AAV/chimeric (Adeno/Retro) vector systems for Atherosclerosis & Duchenne muscular dystrophy (DMD)/muscle disorders, Genetic Disorders/Cancer.
Languages Takis Athanasopoulos speaks:
English
Greek